Earnings Call · Q2 FY2021·2021-08-05

Q2 21EPS -46.15%·Rev n/aQ1 21EPS +15.28%·Rev n/aQ4 20EPS -81.21%·Rev n/aQ3 20EPS -100.00%*·Rev n/a⚠ consensus missing

NOVAVAX INC NVAX

Silvia Taylor — Head of Investor Relations

Stan Erck — Chief Executive Officer

Filip Dubovsky — Chief Medical Officer

John Trizzino — Chief Financial Officer

+12.2%1d on move date+12.3% vs SPY3d+23.4%5d+35.5%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NVAX calls or request research access.

More NVAX calls Browse calls Request research access